Clinical Trial Update: A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing ponatinib to imatinib in adults with Philadelphia chromosome–positive acute lymphoblastic leukemia; results have been posted,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Imatinib (imatinib)
• Ponatinib (ponatinib)

Snippet

Sponsor: Takeda | Conditions: Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-10-27